Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 44 Breast Neoplasms 26 Sarcoma 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Burkitt Lymphoma 14 Neuroblastoma 13 Hodgkin Disease 13 Leukemia 12 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma, Follicular 8 Wilms Tumor 7 Sarcoma, Synovial 7 Neurofibrosarcoma 7 Leiomyosarcoma 7 Histiocytoma, Malignant Fibrous 7 Hemangiosarcoma 7 Fibrosarcoma 7 Endometrial Neoplasms 7 Urinary Bladder Neoplasms 6 Multiple Myeloma 6 Malignant mesenchymal tumor 6 Liposarcoma 6 Rhabdomyosarcoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large-Cell, Anaplastic 5 Kidney Neoplasms 5 Hemangiopericytoma, Malignant 5 Waldenstrom Macroglobulinemia 4 Sarcoma, Alveolar Soft Part 4

Interventions

eribulin 1 Trabectedin 1 Doxorubicin 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Solitary Fibrous Tumors × Doxorubicin × Clear all

NCT03023124 2024-12-09

STRADA

Italian Sarcoma Group

Phase 2 Completed

Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡